Corbin Therapeutics is a spin-off company from AmorChem Fund 1, developing a sophisticated in-vivo genome-wide screening platform in mice undergoing experimental neuro-inflammation, from the laboratory of Dr Philippe Gros, Faculty of Medicine, McGill University, leading to a novel anti-inflammatory target in the deubiquitinylation (DUB) family of enzymes, more particularly USP15.
Corbin Therapeutics is a spin-off company from AmorChem Fund 1, developing a sophisticated in-vivo genome-wide screening platform in mice undergoing experimental neuro-inflammation, from the laboratory of Dr Philippe Gros, Faculty of Medicine, McGill University, leading to a novel anti-inflammatory target in the deubiquitinylation (DUB) family of enzymes, more particularly USP15.
Company Information
- Industry
- Company Type
- Privately Held
- Founded
- 2016
- Employee Range
- Myself Only
- Revenue Range
- Not available
Location
- Address
- 4 Westmount Square Quebec Westmount
- City
- Montreal
- Region
- Quebec
- Postal Code
- H3Z 2S6
- Country
- Canada